{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:46:24Z","timestamp":1791549984508,"version":"4.3.4"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study was aimed to investigate the microstructure characteristics of cornea verticillata and limbus deposits in patients with Fabry disease (FD) using <jats:italic>in vivo<\/jats:italic> confocal microscopy (IVCM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 60 eyes from 30 patients diagnosed with FD were examined and compared with 36 eyes from 18 healthy controls in this prospective, cross-sectional, controlled, single-center study. The initial assessment of cornea verticillata (CV) was conducted using slit-lamp microscopy. Subsequently, IVCM was performed to assess deposits in the corneal and limbal epithelium. We compared the differences between the sexes (heterozygous and hemizygous) and phenotypes (classical and non-classical).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The epithelial deposit detection rate with IVCM was statistically higher (52\/60, 86.67%) compared to the biomicroscopic evaluation of CV using a silt lamp (46\/60, 76.67%) (<jats:italic>p<\/jats:italic>\u202f=\u202f0.031). A higher prevalence of corneal epithelial deposits was observed in the classical phenotype as compared to the non-classical phenotype (<jats:italic>p<\/jats:italic>\u202f=\u202f0.023). Surprisingly, cardiac variants previously lacking cornea verticillata show a high prevalence (85.71%) of corneal epithelial deposits under IVCM. The prevalence and severity of deposits, especially in limbal epithelial rete pegs, were higher in FD than in controls (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Compared with slit-lamp microscopy, IVCM provides a more effective tool for examining the epithelial deposits in patients with FD. Patients with FD demonstrated a profound bilateral increase in corneal epithelial deposits and limbal hyperreflective cells compared to controls, with more prominent pathological changes observed in classical phenotype individuals. The high prevalence of epithelial deposits observed through IVCM in the cardiac variant highlights the essential ability of IVCM as an effective diagnostic tool.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1541510","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:39:06Z","timestamp":1738741146000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["In vivo confocal microscopic study of cornea verticillata and limbus deposits in patients with Fabry disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Xuecong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/jmg-2022-108523","article-title":"Prevalence of Fabry disease-causing variants in the UK biobank","volume":"60","author":"Gilchrist","year":"2023","journal-title":"J Med Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","article-title":"Fabry's disease","volume":"344","author":"El-Abassi","year":"2014","journal-title":"J Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"107603","DOI":"10.1016\/j.ymgme.2023.107603","article-title":"Global reach of over 20 years of experience in the patient-centered Fabry registry: advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry community","volume":"139","author":"Wanner","year":"2023","journal-title":"Mol Genet Metab"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/asn.2016090964","article-title":"Characterization of classical and nonclassical Fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/a:1012443001449","article-title":"An historical overview of Fabry disease","volume":"24","author":"Fabry","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126518","article-title":"Human \u03b1-galactosidase a mutants: priceless tools to develop novel therapies for Fabry disease","volume":"22","author":"Modrego","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1073\/pnas.85.11.3903","article-title":"Structural organization of the human alpha-galactosidase a gene: further evidence for the absence of a 3\u2032 untranslated region","volume":"85","author":"Bishop","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.amjms.2020.07.011","article-title":"When and how to diagnose Fabry disease in clinical Pratice","volume":"360","author":"Michaud","year":"2020","journal-title":"Am J Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"van der Tol","year":"2014","journal-title":"J Med Genet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2215\/cjn.09480819","article-title":"The changing landscape of Fabry disease","volume":"15","author":"Svarstad","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0244279","DOI":"10.1371\/journal.pone.0244279","article-title":"The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysaccharidosis type II: a German-wide telephone survey","volume":"15","author":"Mengel","year":"2020","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1442-9071.2005.00990.x","article-title":"Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre","volume":"33","author":"Nguyen","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1001\/archopht.1979.01020010327008","article-title":"The ocular manifestations in Fabry's disease","volume":"974","author":"Sher","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcae025","article-title":"Cornea verticillata in Fabry disease","author":"Idrus","year":"2024","journal-title":"QJM"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13060904","article-title":"Ophthalmic manifestations in Fabry disease: updated review","volume":"13","author":"Gambini","year":"2023","journal-title":"J Pers Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry's disease: data from the Fabry outcome survey","volume":"91","author":"Sodi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1097\/01.ASN.0000016683.73778.78","article-title":"Natural history and treatment of renal involvement in Fabry disease","volume":"13","author":"Branton","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1076\/opge.24.3.129.15609","article-title":"Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients","volume":"24","author":"Orssaud","year":"2003","journal-title":"Ophthalmic Genet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/bjophthalmol-2014-306433","article-title":"Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review","volume":"100","author":"van der Tol","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10545-010-9166-7","article-title":"Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4\u202f+\u202f919G\u2192a)","volume":"33","author":"Lin","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00417-008-0962-9","article-title":"The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study","volume":"247","author":"Falke","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/ijcp.12016","article-title":"Multidimensional analysis of clinical symptoms in patients with Fabry's disease","volume":"67","author":"Kaminsky","year":"2013","journal-title":"Int J Clin Pract"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.oftal.2011.09.008","article-title":"Ophthalmic manifestations in Mexican patients with Fabry disease","volume":"87","author":"Beltr\u00e1n-Becerra","year":"2012","journal-title":"Arch Soc Esp Oftalmol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1399-0004.2012.01947.x","article-title":"Fabry disease in children: agalsidase-beta enzyme replacement therapy","volume":"83","author":"Borgwardt","year":"2013","journal-title":"Clin Genet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1023\/a:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00417-011-1726-5","article-title":"Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy","volume":"249","author":"Wasielica-Poslednik","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s1542-0124(12)70030-7","article-title":"In vivo confocal microscopy of the ocular surface","volume":"4","author":"Zhivov","year":"2006","journal-title":"Ocul Surf"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/bjophthalmol-2019-314249","article-title":"Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy","volume":"104","author":"Leonardi","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00003226-200103000-00028","article-title":"Histopathologic findings of cornea verticillata in a woman heterozygous for Fabry's disease","volume":"20","author":"Hirano","year":"2001","journal-title":"Cornea"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4252\/wjsc.v7.i2.281","article-title":"Evaluating alternative stem cell hypotheses for adult corneal epithelial maintenance","volume":"7","author":"West","year":"2015","journal-title":"World J Stem Cells"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"5315137","DOI":"10.1155\/2018\/5315137","article-title":"In vivo confocal microscopic observations of Vortex keratopathy in patients with amiodarone-induced keratopathy and Fabry disease","volume":"2018","author":"Ikegawa","year":"2018","journal-title":"J Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/ico.0000000000002285","article-title":"Multifocal vortex keratopathy","volume":"39","author":"Tan","year":"2020","journal-title":"Cornea"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3760\/cma.j.cn112138-20201218-01028","article-title":"[Expert consensus for diagnosis and treatment of Fabry disease in China (2021)]","volume":"604","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \"renal variant\" phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/s0161-6420(84)34165-3","article-title":"Clinical experience and grading of amiodarone keratopathy","volume":"91","author":"Orlando","year":"1984","journal-title":"Ophthalmology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1167\/iovs.05-1492","article-title":"Laser scanning in vivo confocal microscopy of the normal human corneoscleral limbus","volume":"47","author":"Patel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/bjophthalmol-2011-300550","article-title":"In vivo confocal microscopic features of normal limbus","volume":"96","author":"Miri","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"109252","DOI":"10.1016\/j.exer.2022.109252","article-title":"Influence of spiral topographies on human limbal-derived immortalized corneal epithelial cells","volume":"225","author":"Bhattacharjee","year":"2022","journal-title":"Exp Eye Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Investig"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/a:1012447102358","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","volume":"24","author":"MacDermot","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101460","article-title":"An overview of molecular mechanisms in Fabry disease","volume":"12","author":"Amodio","year":"2022","journal-title":"Biomol Ther"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ajmg.a.30123","article-title":"Inheritance of most X-linked traits is not dominant or recessive, just X-linked","author":"Dobyns","year":"2004","journal-title":"Am J Med Genet A"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218080","article-title":"Biomarkers in Anderson-Fabry disease","volume":"21","author":"Simonetta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","article-title":"Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \"kidney disease: improving global outcomes\" (KDIGO) controversies conference","volume":"91","author":"Schiffmann","year":"2017","journal-title":"Kidney Int"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/cge.13546","article-title":"Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients","volume":"96","author":"Germain","year":"2019","journal-title":"Clin Genet"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1541510\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:39:14Z","timestamp":1738741154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1541510\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":48,"alternative-id":["10.3389\/fmed.2025.1541510"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1541510","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"article-number":"1541510"}}